Using candidate-gene approach, we examined the promoter methylation level of AR, ESR1, hTERT, MYC, RASSF1 and WNT1 in 69 male breast tumors and corresponding blood samples, 7 normal breast tissues and 8 normal lymph node samples. Here, MYC is linked to breast neoplasm.